Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs
about
Summary of information on human CYP enzymes: human P450 metabolism data.Single-dose pharmacokinetics of oral and intravenous pantoprazole in children and adolescents.Review article: drug interactions with agents used to treat acid-related diseases.Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy.Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.Pharmacogenetics of the proton pump inhibitors: a systematic review.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophyllinePharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Azole interactions with multidrug therapy in pediatric oncology.pH-dependent drug-drug interactions for weak base drugs: potential implications for new drug development.Interactions of omeprazole-based analogues with cytochrome P450 2C19: a computational study.Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD).Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes.Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers.Resistance to high-maintenance dose of prasugrel treated by ticagrelor: a case report.Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.Urinary 6-hydroxymelatonin sulfate excretion in intellectually disabled subjects with sleep disorders and multiple medications: validation of measurements in urine extracted from diapers.Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazole.Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells.
P2860
Q32103802-8A486FB3-612C-4539-8CC6-2F2653523C3BQ33355914-0058B0D3-8182-4300-95DE-A2E07963AAFDQ33734848-90DDA06A-EF56-4EB8-81A6-A0411A8478E7Q33734852-12601B13-047C-4FD9-A509-A7E7E5A39C17Q33771058-E8386D39-CC8C-43C9-A047-2D3026AE2240Q33792368-233AD75A-81DF-4E48-B32A-67050D4306D2Q33912651-B98E2F4B-CC78-4CC7-A0CA-5FDF853A4DD1Q34532600-0F7BD2EF-7C57-473D-8120-EBD91A7EFF8EQ35598058-19F69A28-056B-4DE4-A6CB-753738979A7BQ35803627-C4E0F4DC-B655-4330-B7DC-0645B5D2A43CQ36053752-3EEDADB8-0CF5-4D06-B09B-0594636284F7Q36365500-0471D83E-18BF-432B-9E68-ED2494A0CE0FQ38015710-CB59274D-9647-44B1-8F6B-EF607209C896Q38204680-00B8608A-B0A2-4415-AB21-2D22C3608E5EQ38878454-F4979A26-D924-41E9-82A2-3AF3A9DE4922Q39346143-F833C31A-641B-4816-98BA-91E4B4F633C0Q43622668-66D9CD8E-A392-4004-BD69-6DF4A5197001Q43734597-1E46D52B-1698-4662-801F-BD37741AED51Q44139577-9363C0AA-8B59-4CB2-8617-3A93242E24DBQ44264585-ED96037D-0C7F-458E-B7A8-68A28D63B698Q46349067-F54B938A-40BE-4C37-BA10-2E65EA7E6F61Q46635566-7759AF9B-1D4D-49D4-B503-549B1E0A7AFCQ51461774-4FD5A869-3D0A-4915-8003-DD4012B46430Q54470777-7F2D66D4-CF00-42E2-AFF8-825E280F3768
P2860
Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs
description
article
@en
im Oktober 1996 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1996
@uk
ലേഖനം
@ml
name
Metabolic interactions of the ...... pantoprazole with other drugs
@en
Metabolic interactions of the ...... pantoprazole with other drugs
@nl
type
label
Metabolic interactions of the ...... pantoprazole with other drugs
@en
Metabolic interactions of the ...... pantoprazole with other drugs
@nl
prefLabel
Metabolic interactions of the ...... pantoprazole with other drugs
@en
Metabolic interactions of the ...... pantoprazole with other drugs
@nl
P1476
Metabolic interactions of the ...... pantoprazole with other drugs
@en
P2093
Urs A. Meyer
P304
P356
10.1097/00042737-199610001-00005
P433
Supplement 1
P577
1996-10-01T00:00:00Z